home / stock / knbif / knbif articles

KNBIF Articles, Kane Biotech - From 05/16/24

Stock Information
Company Name: Kane Biotech
Stock Symbol: KNBIF
Market: OTC
Website: kanebiotech.com
Menu
KNBIF KNBIF Quote KNBIF Short KNBIF News KNBIF Articles KNBIF Message Board
Get KNBIF Alerts

News, Short Squeeze, Breakout and More Instantly...
Kane Biotech to Release First Quarter 2024 Financial Results on May 23, 2024 | Benzinga

WINNIPEG, Manitoba, May 16, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. ((TSX- V:KNE, OTCQB:KNBIF) (the "Company" or "Kane Biotech"), a biotechno...
Kane Biotech to Host Investor Webinar | Benzinga

WINNIPEG, Manitoba, April 16, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. ((TSX- V:KNE, OTCQB:KNBIF) ("Kane") announces that it will be hosting a...

Kane Biotech Announces Agreement in Principle for the Sale of its Interest in STEM Animal Health | Benzinga

WINNIPEG, Manitoba, April 11, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. ((TSX- V:KNE, OTCQB:KNBIF) (the "Company" or "Kane Biotech") announces ...

Kane Biotech Extends Exclusivity Period on its Offer for its Interest in STEM Animal Health | Benzinga

WINNIPEG, Manitoba, March 20, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. ((TSX- V:KNE, OTCQB:KNBIF) (the "Company" or "Kane Biotech"), announces...
Kane Biotech to Release Fourth Quarter and Full Year 2023 Financial Results on March 26, 2024 – Conference Call to Follow | Benzinga

WINNIPEG, Manitoba, March 19, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. ((TSX- V:KNE, OTCQB:KNBIF) (the "Company" or "Kane Biotech"), a biotech...

Dr. Robert Huizinga Elected to the Kane Biotech Board and Appointed Executive Chair | Benzinga

WINNIPEG, Manitoba, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSXV:KNE, OTCQB:KNBIF) (the "Company" or "Kane Biotech" or "Kane") anno...

Kane Biotech Files New Patent on revyve™ Antimicrobial Wound Gel Spray | Benzinga

WINNIPEG, Manitoba, Jan. 31, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSXV:KNE, OTCQB:KNBIF) (the "Company" or "Kane Biotech" or "Kane") anno...
Kane Biotech to Present its revyve™ Antimicrobial Wound Gel at Boswick Burn and Wound Care Symposium | Benzinga

WINNIPEG, Manitoba, Jan. 25, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSXV:KNE, OTCQB:KNBIF) (the "Company" or "Kane Biotech" or "Kane") toda...

Kane Biotech Announces Correction to Press Release | Benzinga

WINNIPEG, Manitoba, Dec. 29, 2023 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSXV:KNE, OTCQB:KNBIF) (the "Company", "Kane" or "Kane Biotech") today ...

Kane Biotech Announces Amendment to its Credit Facility | Benzinga

WINNIPEG, Manitoba, Dec. 28, 2023 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSXV:KNE, OTCQB:KNBIF) (the "Company", "Kane" or "Kane Biotech") announ...
Previous 10 Next 10